Patents

Oragenics Obtains U.S. Patent for IVIAT

October 17, 2011

Oragenics, Inc., Tampa, FL, has been issued patent No. 8,034,571 from the U.S. Patent and Trademark office for In Vivo Induced Antigen Technology (IVIAT). This platform technology is a novel approach for studying microbial pathogenesis that identifies genes of a pathogenic organism, which are differentially expressed during an actual human infection. IVIAT can be applied to all pathogenic bacteria, yeasts and parasites to rapidly identify proteins that are expressed when a pathogen infects a human. Such proteins are excellent targets for medical diagnostics and therapeutic strategies.
blog comments powered by Disqus
  • Herbs & Botanicals Bounce Back

    Herbs & Botanicals Bounce Back

    Lisa Olivo, Associate Editor||July 1, 2016
    Industry rallies to cultivate quality with hopes of ensuring long-term market health.

  • Healthy Beverage Market Overflowing With Opportunities

    Healthy Beverage Market Overflowing With Opportunities

    Sean Moloughney, Editor||July 1, 2016
    Clean and simple formulas that incorporate vital nutrients will continue to gain market share.

  • Choosing The Right Analytical Lab

    Choosing The Right Analytical Lab

    Maged Sharaf, PhD, American Herbal Products Association ||July 1, 2016
    Here are some important questions to consider when determining which contract laboratory will meet your needs.